12-Month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency

Pituitary

Volumn 16, Issue 3, 2013, Pages 311-318

  Biller, Beverly M K ^a   Ji, Hyi Jeong ^b   Ahn, Hyunji ^b   Savoy, Conrad ^c   Siepl, E Christine ^c   Popovic, Vera ^d   Coculescu, Mihail ^e   Roemmler, Josefine ^g   Gavrila, Catalin ^f   Cook, David M ^h   Strasburger, Christian J ⁱ  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LG Chemical Ltd   (South Korea)

^c BioPartners GmbH   (Switzerland)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

^f SANA Medical Center   (Romania)

^g UNIVERSITY OF MUNICH   (Germany)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adult GH deficiency; LB03002; Long term safety; Sustained release GH; Weekly

Indexed keywords

HUMAN GROWTH HORMONE; PLACEBO; SOMATOMEDIN C;

ADULT; ARTHRALGIA; ARTICLE; ASTHENIA; CHRONIC DRUG ADMINISTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED CANCER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSGEUSIA; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INJECTION SITE DISCOMFORT; INJECTION SITE REACTION; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOPLASM; PERIPHERAL EDEMA; PRIORITY JOURNAL; RHINOPHARYNGITIS; SIDE EFFECT; SUSTAINED RELEASE PREPARATION; TREATMENT DURATION;

EID: 84881343642     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-012-0422-8     Document Type: Article

References (13)

1. Rosenfeld RG, Bakker B (2008) Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract 14:143-154
2. Reiter EO, Attie KM, Moshang T Jr, Silverman BL, Kemp SE, Neuwirth RB, Ford KM, Saenger P, Genentech Inc.-Alkermes Inc. Collaborative Study Group (2001) A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency. J Clin Endocrinol Metab 86:4700-4706
3. Cook DM, Biller BM, Vance ML, Hoffman AR, Phillips LS, Ford KM, Benziger DP, Illeperuma A, Blethen SL, Attie KM, Dao LN, Reimann JD, Fielder PJ (2002) The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (Nutropin depot) in GH deficient adults. J Clin Endocrinol Metab 87:4508-4514
4. Hoffman AR, Biller BMK, Cook D, Baptista J, Silverman BL, Dao L, Attie KM, Fielder P, Maneatis T, Lippe B, Genentech Adult Growth Hormone Deficiency Study Group (2005) Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J Clin Endocrinol Metab 90:6431-6440
5. Biller BMK, Ji H-J, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ (2011) Effects of once-weekly sustained-release growth hormone: double-blind, placebo-controlled study in adult growth hormone deficiency. J Clin Endocrinol Metab 96(6):1718-1726. doi: 10.1210/jc.2010-2819
6. American Diabetes Association (2010) Standards of medical care in diabetes-2010. Diabetes Care 33(Suppl 1):S11-S61
7. Spielhagen C, Schwahn C, Moller K, Friedrich N, Kohlmann T, Moock J, Koltowska-Haggstrom M, Nauck M, Buchfelder M, Wallaschofski H (2011) The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database. Growth Horm IGF Res 21:1-10
8. Svensson J, Bengtsson BA (2009) Safety aspects of GH replacement. Eur J Endocrinol 161(Suppl 1):S65-S74
9. Hoffman AR, Strasburger CJ, Zagar A, Blum WF, Kehely A, Hartman ML, T002 Study Group (2004) Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing. J Clin Endocrinol Metab 89:3224-3233
10. Peterkova V, Arslanoglu I, Bolshova-Zukovskaya E, Romer T, Zdravkovic D, Kratzsch J, Ji HJ, Savoy C, Saenger P (2007) A randomized, double-blind study to assess the efficacy and safety of Valtropin, a biosimilar growth hormone, in children with growth hormone deficiency. Horm Res 68:288-293
11. Pirazolli P, Cacciari E, Mandini M, Cicognani A, Zucchini S, Sganga T, Capelli M (1995) Follow-up of antibodies to growth hormone in 210 growth hormone-deficient children treated with different commercial preparations. Acta Pediatr 84:1233-1236
12. Riente L, Chimenti D, Pratesi F, Sedie AD, Tommasi S, Tommasi C, Bombardieri S, Migliorini P (2004) Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. J Rheumatol 31:920-924
13. Walker LJ, Aldhous MC, Drummond HE, Smith BR, Nimmo ER, Arnott ID, Satsangi J (2004) Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol 135:490-496